Astrogliopathology: Could nanotechnology restore aberrant calcium signalling and pathological astroglial remodelling?

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1833, Issue 7, 2013, Pages 1625-1631

  Parpura, Vladimir ^a,b   Verkhratsky, Alexei ^c,d,e  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b University of Rijeka   (Croatia)

^c BASQUE FOUNDATION FOR SCIENCE   (Spain)

^d UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^e UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Astrocyte; Calcium; Carbon nanotube; Morphology; Nanomedicine; Nanotechnology

Indexed keywords

CALCIUM; CARBON NANOTUBE;

ASTROCYTE; ASTROCYTOSIS; CALCIUM SIGNALING; GLIA CELL; HOMEOSTASIS; HUMAN; MACROGLIA; MAMMAL; NANOTECHNOLOGY; NEUROPATHOLOGY; NEUROPROSTHESIS; OLIGODENDROGLIA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; WALLERIAN DEGENERATION;

ANIMALS; ASTROCYTES; BRAIN DISEASES; CALCIUM SIGNALING; HUMANS; NANOTECHNOLOGY; NANOTUBES, CARBON;

MAMMALIA;

EID: 84878264336     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2012.11.023     Document Type: Review

References (98)

1. Virchow R. Die Cellularpathologie in ihrer Begründung auf physiologische and pathologische Gewebelehre. Zwanzig Vorlesungen gehalten während der Monate Februar, März und April 1858 im pathologischen Institut zu Berlin 1858, August Hirschwald, Berlin. First edition.
2. Golgi C. Sulla sostanza connettiva del cervello (nevroglia), Rendiconti del R. Instituto Lombardo di Scienze e Lettere serie 2 1870, v. 3:275-277.
3. Golgi C. Opera Omnia 1903, Hoepli, Milano.
4. Lenhossek M. v., Lenhossék M. v Der feinere Bau des Nervensystems im Lichte neuester Forschung 1895, Fischer's Medicinische Buchhandlung H. Kornfield, Berlin. 2nd edition.
5. Hanisch U.K., Kettenmann H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat. Neurosci. 2007, 10:1387-1394.
6. Kettenmann H., Hanisch U.K., Noda M., Verkhratsky A. Physiology of microglia. Physiol. Rev. 2011, 91:461-553.
7. Verkhratsky A. Physiology of neuronal-glial networking. Neurochem. Int. 2010, 57:332-343.
8. Verkhratsky A., Butt A. Glial neurobiology. A Textbook 2007, John Wiley & Sons, Chichester.
9. Neuroglia 2012, OUP, Oxford. H. Kettenmann, B.R. Ransom (Eds.).
10. Hanani M. Satellite glial cells in sympathetic and parasympathetic ganglia: in search of function. Brain Res. Rev. 2010, 64:304-327.
11. Verkhratsky A., Sofroniew M.V., Messing A., deLanerolle N.C., Rempe D., Rodriguez J.J., Nedergaard M. Neurological diseases as primary gliopathies: a reassessment of neurocentrism. ASN Neuro 2012, 4:e00082.
12. Sofroniew M.V. Molecular dissection of reactive astrogliosis and glial scar formation. Trends Neurosci. 2009, 32:638-647.
13. Parpura V., Heneka M.T., Montana V., Oliet S.H., Schousboe A., Haydon P.G., Stout R.F., Spray D.C., Reichenbach A., Pannicke T., Pekny M., Pekna M., Zorec R., Verkhratsky A. Glial cells in (patho)physiology. J. Neurochem. 2012, 121:4-27.
14. Nedergaard M., Rodriguez J.J., Verkhratsky A. Glial calcium and diseases of the nervous system. Cell Calcium 2010, 47:140-149.
15. Giaume C., Kirchhoff F., Matute C., Reichenbach A., Verkhratsky A. Glia: the fulcrum of brain diseases. Cell Death Differ. 2007, 14:1324-1335.
16. De Keyser J., Mostert J.P., Koch M.W. Dysfunctional astrocytes as key players in the pathogenesis of central nervous system disorders. J. Neurol. Sci. 2008, 267:3-16.
17. Cornell Bell A.H., Finkbeiner S.M., Cooper M.S., Smith S.J. Glutamate induces calcium waves in cultured astrocytes: long-range glial signaling. Science 1990, 247:470-473.
18. Verkhratsky A., Orkand R.K., Kettenmann H. Glial calcium: homeostasis and signaling function. Physiol. Rev. 1998, 78:99-141.
19. Verkhratsky A., Rodriguez J.J., Parpura V. Calcium signalling in astroglia. Mol. Cell. Endocrinol. 2012, 353:45-56.
20. Verkhratsky A., Rodriguez J.J., Parpura V. Neurotransmitters and integration in neuronal-astroglial networks. Neurochem. Res. 2012, 37:2326-2338.
21. Verkhratsky A., Krishtal O.A., Burnstock G. Purinoceptors on neuroglia. Mol. Neurobiol. 2009, 39:190-208.
22. Bekar L.K., He W., Nedergaard M. Locus coeruleus α-adrenergic-mediated activation of cortical astrocytes in vivo. Cereb. Cortex 2008, 18:2789-2795.
23. Duffy S., MacVicar B.A. Adrenergic calcium signaling in astrocyte networks within the hippocampal slice. J. Neurosci. 1995, 15:5535-5550.
24. Kirischuk S., Moller T., Voitenko N., Kettenmann H., Verkhratsky A. ATP-induced cytoplasmic calcium mobilization in Bergmann glial cells. J. Neurosci. 1995, 15:7861-7871.
25. i in hippocampal astrocytes in situ. J. Neurochem. 1995, 65:1515-1523.
26. Porter J.T., McCarthy K.D. GFAP-positive hippocampal astrocytes in situ respond to glutamatergic neuroligands with increases in [Ca2+]i. Glia 1995, 13:101-112.
27. 2+ signaling evoked by sensory stimulation in vivo. Nat. Neurosci. 2006, 9:816-823.
28. 2+ dynamics and consequent glutamate release from rat astrocytes. Glia 2008, 56:821-835.
29. Lalo U., Palygin O., North R.A., Verkhratsky A., Pankratov Y. Age-dependent remodelling of ionotropic signalling in cortical astroglia. Aging Cell 2011, 10:392-402.
30. Lalo U., Pankratov Y., Kirchhoff F., North R.A., Verkhratsky A. NMDA receptors mediate neuron-to-glia signaling in mouse cortical astrocytes. J. Neurosci. 2006, 26:2673-2683.
31. 5 subunits form the functional P2X receptor in mouse cortical astrocytes. J. Neurosci. 2008, 28:5473-5480.
32. Lalo U., Pankratov Y., Parpura V., Verkhratsky A. Ionotropic receptors in neuronal-astroglial signalling: what is the role of "excitable" molecules in non-excitable cells. Biochim. Biophys. Acta 2011, 1813:992-1002.
33. 2+ signalling in cortical astrocytes. Cell Calcium 2010, 48:225-231.
34. Kirischuk S., Parpura V., Verkhratsky A. Sodium dynamics: another key to astroglial excitability?. Trends Neurosci. 2012, 35:497-506.
35. 2+-dependent exocytotic release of glutamate from rat cortical astrocytes. ASN Neuro 2012, 4:e00075.
36. Takano T., Oberheim N., Cotrina M.L., Nedergaard M. Astrocytes and ischemic injury. Stroke 2009, 40:S8-S12.
37. de Lanerolle N.C., Lee T.S. New facets of the neuropathology and molecular profile of human temporal lobe epilepsy. Epilepsy Behav. 2005, 7:190-203.
38. Seifert G., Schilling K., Steinhauser C. Astrocyte dysfunction in neurological disorders: a molecular perspective. Nat. Rev. Neurosci. 2006, 7:194-206.
39. Binder D.K., Steinhauser C. Functional changes in astroglial cells in epilepsy. Glia 2006, 54:358-368.
40. Inyushin M., Kucheryavykh L.Y., Kucheryavykh Y.V., Nichols C.G., Buono R.J., Ferraro T.N., Skatchkov S.N., Eaton M.J. Potassium channel activity and glutamate uptake are impaired in astrocytes of seizure-susceptible DBA/2 mice. Epilepsia 2010, 51:1707-1713.
41. Carmignoto G., Haydon P.G. Astrocyte calcium signaling and epilepsy. Glia 2012, 60:1227-1233.
42. Seifert G., Schroder W., Hinterkeuser S., Schumacher T., Schramm J., Steinhauser C. Changes in flip/flop splicing of astroglial AMPA receptors in human temporal lobe epilepsy. Epilepsia 2002, 43(Suppl. 5):162-167.
43. Manning T.J., Sontheimer H. Spontaneous intracellular calcium oscillations in cortical astrocytes from a patient with intractable childhood epilepsy (Rasmussen's encephalitis). Glia 1997, 21:332-337.
44. Tian G.F., Azmi H., Takano T., Xu Q., Peng W., Lin J., Oberheim N., Lou N., Wang X., Zielke H.R., Kang J., Nedergaard M. An astrocytic basis of epilepsy. Nat. Med. 2005, 11:973-981.
45. Abramov A.Y., Canevari L., Duchen M.R. Changes in intracellular calcium and glutathione in astrocytes as the primary mechanism of amyloid neurotoxicity. J. Neurosci. 2003, 23:5088-5095.
46. Kuchibhotla K.V., Lattarulo C.R., Hyman B.T., Bacskai B.J. Synchronous hyperactivity and intercellular calcium waves in astrocytes in Alzheimer mice. Science 2009, 323:1211-1215.
47. Hazell A.S. Astrocytes are a major target in thiamine deficiency and Wernicke's encephalopathy. Neurochem. Int. 2009, 55:129-135.
48. Hazell A.S., Sheedy D., Oanea R., Aghourian M., Sun S., Jung J.Y., Wang D., Wang C. Loss of astrocytic glutamate transporters in Wernicke encephalopathy. Glia 2009, 58:148-156.
49. Johnston-Wilson N.L., Sims C.D., Hofmann J.P., Anderson L., Shore A.D., Torrey E.F., Yolken R.H. Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder. The Stanley Neuropathology Consortium. Mol. Psychiatry 2000, 5:142-149.
50. Mori T., Ohnishi T., Hashimoto R., Nemoto K., Moriguchi Y., Noguchi H., Nakabayashi T., Hori H., Harada S., Saitoh O., Matsuda H., Kunugi H. Progressive changes of white matter integrity in schizophrenia revealed by diffusion tensor imaging. Psychiatry Res. 2007, 154:133-145.
51. Rajkowska G., Miguel-Hidalgo J.J., Makkos Z., Meltzer H., Overholser J., Stockmeier C. Layer-specific reductions in GFAP-reactive astroglia in the dorsolateral prefrontal cortex in schizophrenia. Schizophr. Res. 2002, 57:127-138.
52. Oliet S.H., Mothet J.P. Molecular determinants of d-serine-mediated gliotransmission: from release to function. Glia 2006, 54:726-737.
53. Henneberger C., Papouin T., Oliet S.H., Rusakov D.A. Long-term potentiation depends on release of d-serine from astrocytes. Nature 2010, 463:232-236.
54. Rajkowska G., Miguel-Hidalgo J.J. Gliogenesis and glial pathology in depression. CNS Neurol. Disord. Drug Targets 2007, 6:219-233.
55. Si X., Miguel-Hidalgo J.J., O'Dwyer G., Stockmeier C.A., Rajkowska G. Age-dependent reductions in the level of glial fibrillary acidic protein in the prefrontal cortex in major depression. Neuropsychopharmacology 2004, 29:2088-2096.
56. Gosselin R.D., Gibney S., O'Malley D., Dinan T.G., Cryan J.F. Region specific decrease in glial fibrillary acidic protein immunoreactivity in the brain of a rat model of depression. Neuroscience 2009, 159:915-925.
57. Verkhratsky A., Olabarria M., Noristani H.N., Yeh C.Y., Rodriguez J.J. Astrocytes in Alzheimer's disease. Neurotherapeutics 2010, 7:399-412.
58. Rossi D., Volterra A. Astrocytic dysfunction: insights on the role in neurodegeneration. Brain Res. Bull. 2009, 80:224-232.
59. Rodriguez J.J., Verkhratsky A. Neuroglial roots of neurodegenerative diseases?. Mol. Neurobiol. 2011, 43:87-96.
60. Rossi D., Brambilla L., Valori C.F., Roncoroni C., Crugnola A., Yokota T., Bredesen D.E., Volterra A. Focal degeneration of astrocytes in amyotrophic lateral sclerosis. Cell Death Differ. 2008, 15:1691-1700.
61. Staats K.A., Van Den Bosch L. Astrocytes in amyotrophic lateral sclerosis: direct effects on motor neuron survival. J. Biol. Phys. 2009, 35:337-346.
62. Wang L., Gutmann D.H., Roos R.P. Astrocyte loss of mutant SOD1 delays ALS disease onset and progression in G85R transgenic mice. Hum. Mol. Genet. 2011, 20:286-293.
63. Yamanaka K., Chun S.J., Boillee S., Fujimori-Tonou N., Yamashita H., Gutmann D.H., Takahashi R., Misawa H., Cleveland D.W. Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat. Neurosci. 2008, 11:251-253.
64. Kulijewicz-Nawrot M., Verkhratsky A., Chvatal A., Sykova E., Rodriguez J.J. Astrocytic cytoskeletal atrophy in the medial prefrontal cortex of a triple transgenic mouse model of Alzheimer's disease. J. Anat. 2012, 221:252-262.
65. Olabarria M., Noristani H.N., Verkhratsky A., Rodriguez J.J. Concomitant astroglial atrophy and astrogliosis in a triple transgenic animal model of Alzheimer's disease. Glia 2010, 58:831-838.
66. Yeh C.Y., Vadhwana B., Verkhratsky A., Rodriguez J.J. Early astrocytic atrophy in the entorhinal cortex of a triple transgenic animal model of Alzheimer's disease. ASN Neuro 2012, 3:271-279.
67. Johnson K.A., Fox N.C., Sperling R.A., Klunk W.E. Brain imaging in Alzheimer disease. Cold Spring Harb. Perspect. Med. 2012, 2:a006213.
68. Huang Y., Mucke L. Alzheimer mechanisms and therapeutic strategies. Cell 2012, 148:1204-1222.
69. Broe M., Kril J., Halliday G.M. Astrocytic degeneration relates to the severity of disease in frontotemporal dementia. Brain 2004, 127:2214-2220.
70. Kersaitis C., Halliday G.M., Kril J.J. Regional and cellular pathology in frontotemporal dementia: relationship to stage of disease in cases with and without Pick bodies. Acta Neuropathol. 2004, 108:515-523.
71. Potts R., Leech R.W. Thalamic dementia: an example of primary astroglial dystrophy of Seitelberger. Clin. Neuropathol. 2005, 24:271-275.
72. Rosenbaum A.I., Maxfield F.R. Niemann-Pick type C disease: molecular mechanisms and potential therapeutic approaches. J. Neurochem. 2011, 116:789-795.
73. Estrada-Sánchez A.M., Rebec G.V. Corticostriatal dysfunction and glutamate transporter 1 (GLT1) in Huntington's disease: interactions between neurons and astrocytes. Basal Ganglia. 2012, 2:57-66.
74. Radushkevich L., Lukyanovich V. On the carbon structure occurring following thermal degradation of carbon dioxide on ferrum surface. Zurn Fisic Chim 1952, 26:88-95. (In Russian).
75. Iijima S., Ichihashi T. Single-shell carbon nanotubes of 1-nm diameter. Nature 1993, 363:603-605.
76. Bethune D., Kiang C., De Vries M., Gorman G., Savoy R. Cobalt catalysed growth of carbon nanotubes with single-atomic-layer walls. Nature 1993, 363.
77. Monthioux M., Kuznetsov V. Who should be given the credit for the discovery of carbon nanotubes?. Carbon 2006, 44:1621-1623.
78. Bekyarova E., Ni Y., Malarkey E.B., Montana V., McWilliams J.L., Haddon R.C., Parpura V. Applications of carbon nanotubes in biotechnology and biomedicine. J. Biomed. Nanotechnol. 2005, 1:3-17.
79. Malarkey E.B., Parpura V. Applications of carbon nanotubes in neurobiology. Neurodegener. Dis. 2007, 4:292-299.
80. Bekyarova E., Haddon R.C., Parpura V. Biofunctionalization of carbon nanotubes. Nanotechnologies for the Life Sciences 2005, John Wiley & Sons. Kumar (Ed.).
81. Ni Y., Hu H., Malarkey E.B., Zhao B., Montana V., Haddon R.C., Parpura V. Chemically functionalized water soluble single-walled carbon nanotubes modulate neurite outgrowth. J. Nanosci. Nanotechnol. 2005, 5:1707-1712.
82. Malarkey E.B., Fisher K.A., Bekyarova E., Liu W., Haddon R.C., Parpura V. Conductive single-walled carbon nanotube substrates modulate neuronal growth. Nano Lett. 2009, 9:264-268.
83. Gottipati M.K., Kalinina I., Bekyarova E., Haddon R.C., Parpura V. Chemically functionalized water-soluble single-walled carbon nanotubes modulate morpho-functional characteristics of astrocytes. Nano Lett. 2012, 12:4742-4747.
84. Park K.H., Chhowalla M., Iqbal Z., Sesti F. Single-walled carbon nanotubes are a new class of ion channel blockers. J. Biol. Chem. 2003, 278:50212-50216.
85. Chhowalla M., Unalan H.E., Wang Y.B., Iqbal Z., Park K., Sesti F. Irreversible blocking of ion channels using functionalized single-walled carbon nanotubes. Nanotechnology 2005, 16:2982-2986.
86. Mattson M.P., Kater S.B. Calcium regulation of neurite elongation and growth cone motility. J. Neurosci. 1987, 7:4034-4043.
87. Mattson M.P., Haddon R.C., Rao A.M. Molecular functionalization of carbon nanotubes and use as substrates for neuronal growth. J. Mol. Neurosci. 2000, 14:175-182.
88. Mark R.J., Lovell M.A., Markesbery W.R., Uchida K., Mattson M.P. A role for 4-hydroxynonenal, an aldehydic product of lipid peroxidation, in disruption of ion homeostasis and neuronal death induced by amyloid beta-peptide. J. Neurochem. 1997, 68:255-264.
89. Kater S.B., Mattson M.P., Cohan C., Connor J. Calcium regulation of the neuronal growth cone. Trends Neurosci. 1988, 11:315-321.
90. Uchida K., Stadtman E.R. Modification of histidine residues in proteins by reaction with 4-hydroxynonenal. Proc. Natl. Acad. Sci. U. S. A. 1992, 89:4544-4548.
91. Mattson M.P., Taylor-Hunter A., Kater S.B. Neurite outgrowth in individual neurons of a neuronal population is differentially regulated by calcium and cyclic AMP. J. Neurosci. 1988, 8:1704-1711.
92. Zakharenko S., Popov S. Plasma membrane recycling and flow in growing neurites. Neuroscience 2000, 97:185-194.
93. Malarkey E.B., Reyes R.C., Zhao B., Haddon R.C., Parpura V. Water soluble single-walled carbon nanotubes inhibit stimulated endocytosis in neurons. Nano Lett. 2008, 8:3538-3542.
94. Jakubek L.M., Marangoudakis S., Raingo J., Liu X., Lipscombe D., Hurt R.H. The inhibition of neuronal calcium ion channels by trace levels of yttrium released from carbon nanotubes. Biomaterials 2009, 30:6351-6357.
95. Lee W., Parpura V. Chapter 6-carbon nanotubes as substrates/scaffolds for neural cell growth. Prog. Brain Res. 2009, 180:110-125.
96. Roman J.A., Niedzielko T.L., Haddon R.C., Parpura V., Floyd C.L. Single-walled carbon nanotubes chemically functionalized with polyethylene glycol promote tissue repair in a rat model of spinal cord injury. J. Neurotrauma 2011, 28:2349-2362.
97. Wilms H., Hartmann D., Sievers J. Ramification of microglia, monocytes and macrophages in vitro: influences of various epithelial and mesenchymal cells and their conditioned media. Cell Tissue Res. 1997, 287:447-458.
98. Iijima S. Helical microtubules of graphitic carbon. Nature 1991, 354:56-58.